TruScreen, the company which develops cancer tests says its annual sales won't meet forecasts because of a delay in the launch of an upgraded screening device.
TruScreen, the company which develops cancer tests says its annual sales won't meet forecasts because of a delay in the launch of an upgraded screening device.